152 related articles for article (PubMed ID: 37227514)
21. Portraying breast cancers with long noncoding RNAs.
Van Grembergen O; Bizet M; de Bony EJ; Calonne E; Putmans P; Brohée S; Olsen C; Guo M; Bontempi G; Sotiriou C; Defrance M; Fuks F
Sci Adv; 2016 Sep; 2(9):e1600220. PubMed ID: 27617288
[TBL] [Abstract][Full Text] [Related]
22. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
23. A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype.
Cedro-Tanda A; Ríos-Romero M; Romero-Córdoba S; Cisneros-Villanueva M; Rebollar-Vega RG; Alfaro-Ruiz LA; Jiménez-Morales S; Domínguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Bautista-Piña V; Beltrán-Anaya FO; Hidalgo-Miranda A
Sci Rep; 2020 Aug; 10(1):13146. PubMed ID: 32753692
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes.
Reiche K; Kasack K; Schreiber S; Lüders T; Due EU; Naume B; Riis M; Kristensen VN; Horn F; Børresen-Dale AL; Hackermüller J; Baumbusch LO
PLoS One; 2014; 9(9):e106076. PubMed ID: 25264628
[TBL] [Abstract][Full Text] [Related]
25. lncExplore: a database of pan-cancer analysis and systematic functional annotation for lncRNAs from RNA-sequencing data.
Lee YW; Chen M; Chung IF; Chang TY
Database (Oxford); 2021 Aug; 2021():. PubMed ID: 34464437
[TBL] [Abstract][Full Text] [Related]
26. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Xiao R; Yang M; Tan Y; Ding R; Li D
Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
[TBL] [Abstract][Full Text] [Related]
27. Subtype and cell type specific expression of lncRNAs provide insight into breast cancer.
Bjørklund SS; Aure MR; Häkkinen J; Vallon-Christersson J; Kumar S; Evensen KB; Fleischer T; Tost J; ; Sahlberg KK; Mathelier A; Bhanot G; Ganesan S; Tekpli X; Kristensen VN
Commun Biol; 2022 Aug; 5(1):834. PubMed ID: 35982125
[TBL] [Abstract][Full Text] [Related]
28. The hypoxia-responsive long non-coding RNAs may impact on the tumor biology and subsequent management of breast cancer.
Kapinova A; Kubatka P; Zubor P; Golubnitschaja O; Dankova Z; Uramova S; Pilchova I; Caprnda M; Opatrilova R; Richnavsky J; Kruzliak P; Danko J
Biomed Pharmacother; 2018 Mar; 99():51-58. PubMed ID: 29324312
[TBL] [Abstract][Full Text] [Related]
29. lncSLdb: a resource for long non-coding RNA subcellular localization.
Wen X; Gao L; Guo X; Li X; Huang X; Wang Y; Xu H; He R; Jia C; Liang F
Database (Oxford); 2018 Jan; 2018():1-6. PubMed ID: 30219837
[TBL] [Abstract][Full Text] [Related]
30. Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes.
Wang L; Li J; Zhao H; Hu J; Ping Y; Li F; Lan Y; Xu C; Xiao Y; Li X
Mol Biosyst; 2016 Mar; 12(3):711-20. PubMed ID: 26725846
[TBL] [Abstract][Full Text] [Related]
31. Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data.
Gao Y; Shang S; Guo S; Li X; Zhou H; Liu H; Sun Y; Wang J; Wang P; Zhi H; Li X; Ning S; Zhang Y
Nucleic Acids Res; 2021 Jan; 49(D1):D1251-D1258. PubMed ID: 33219685
[TBL] [Abstract][Full Text] [Related]
32. Novel lncRNAs with diagnostic or prognostic value screened out from breast cancer via bioinformatics analyses.
Wang H; Shu L; Niu N; Zhao C; Lu S; Li Y; Wang H; Liu Y; Zou T; Zou J; Wu X; Wang Y
PeerJ; 2022; 10():e13641. PubMed ID: 35855425
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
[TBL] [Abstract][Full Text] [Related]
34. The LncRNA Connectivity Map: Using LncRNA Signatures to Connect Small Molecules, LncRNAs, and Diseases.
Yang H; Shang D; Xu Y; Zhang C; Feng L; Sun Z; Shi X; Zhang Y; Han J; Su F; Li C; Li X
Sci Rep; 2017 Jul; 7(1):6655. PubMed ID: 28751672
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
36. Identification of Potential Long Non-Coding RNA Candidates that Contribute to Triple-Negative Breast Cancer in Humans through Computational Approach.
Rahman MM; Hossain MT; Reza MS; Peng Y; Feng S; Wei Y
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830241
[TBL] [Abstract][Full Text] [Related]
37. EVLncRNAs 2.0: an updated database of manually curated functional long non-coding RNAs validated by low-throughput experiments.
Zhou B; Ji B; Liu K; Hu G; Wang F; Chen Q; Yu R; Huang P; Ren J; Guo C; Zhao H; Zhang H; Zhao D; Li Z; Zeng Q; Yu J; Bian Y; Cao Z; Xu S; Yang Y; Zhou Y; Wang J
Nucleic Acids Res; 2021 Jan; 49(D1):D86-D91. PubMed ID: 33221906
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNAs differential expression in breast cancer subtypes: What do we know?
Mathias C; Zambalde EP; Rask P; Gradia DF; de Oliveira JC
Clin Genet; 2019 May; 95(5):558-568. PubMed ID: 30614523
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer.
Pecero ML; Salvador-Bofill J; Molina-Pinelo S
Cell Oncol (Dordr); 2019 Feb; 42(1):1-12. PubMed ID: 30361825
[TBL] [Abstract][Full Text] [Related]
40. LncRBase: an enriched resource for lncRNA information.
Chakraborty S; Deb A; Maji RK; Saha S; Ghosh Z
PLoS One; 2014; 9(9):e108010. PubMed ID: 25233092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
